DeepMind has given us the 3-D structures of all human proteins. What does it mean for biofacturing?
A handful of tourists are taking joy rides to space, but humanity’s true prospects for thriving on- and off-planet depend on unlocking the microbial factories all around us.
Vytas SunSpiral thinks the field of artificial intelligence is kind of cursed. Not because it can’t solve big problems across many domains — it’s already done that — but because of its name.
Christina Smolke and her lab report a breakthrough in making plant-based medicines that lays the foundation for a flexible, on-demand drug supply chain to replace our current fragmented and slow-moving one. The solution: use yeast instead of plants.
The former CEO of Google thinks we need to act faster on coronavirus, and that the companies to transform themselves now are going to win.
A new partnership between Riffyn and Novozymes is a great example of how lab automation, data processing, and biology and coming together to transform our digital health future.
Small startups and big companies alike are recognizing that modern biotech R&D is as much a data problem as a science problem. Cloud technologies offer a way to bring together massive amounts of complex data to improve the way we feed, fuel, heal, and build our world with biology.
Finding new medicines is like finding a needle in a haystack. By linking a powerful computational approach to advances in chemical manufacturing, this company is making piles of needles.
As the synthetic biology community began to take shape, I took the toughest job I could ever love — and found my passion.
This 2013 Nature op/ed explores a big-tent approach to organizing a national synthetic biology strategy in the U.S.